Robin Wright
Director at Barinthus Biotherapeutics plc. (BRNS)
Robin Wright has filed 6 insider reports with the SEC since February 2023, as director at Barinthus Biotherapeutics plc. (BRNS). Robin Wright made no open-market purchases or sales in the last 12 months. The latest filing, on September 9, 2026, reports sale back to the company at Barinthus Biotherapeutics plc. (BRNS).
- Filings
- 6
- Companies
- 1
- Bought on market
- $36.6K
- Sold on market
- None
Companies where Robin Wright is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| BRNS Barinthus Biotherapeutics plc. | Director | 0 | $36.6K | $2.66 | Sep 9, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 9, 2026BRNSDirector Wright Robin returned 48,256 units of Ordinary Shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Jun 10, 2025BRNSSEC Form 4 filed by Director Wright RobinForm 4Grant or award
- May 10, 2024BRNSSEC Form 4 filed by Wright RobinForm 4Grant or award
- May 25, 2023+$36.6KBRNSSEC Form 4 filed by Wright RobinForm 4Open-market purchase
- May 11, 2023BRNSSEC Form 4 filed by Wright RobinForm 4Grant or award
- Feb 10, 2023BRNSSEC Form 5 filed by Wright RobinForm 5
Compare Robin Wright with
- Robin Wright vs Joseph Scheeren1 shared
- Robin Wright vs Anne M. Phillips1 shared
- Robin Wright vs Pierre A. Morgon1 shared
- Robin Wright vs Alex Hammacher1 shared
- Robin Wright vs Leon Hooftman1 shared
- Robin Wright vs William Enright1 shared
Other insiders at the same companies
- Oxford Science Enterprises plcBRNS
- Joseph ScheerenBRNS
- Anne M. PhillipsBRNS
- Leon HooftmanBRNS
- Pierre A. MorgonBRNS
- Alex HammacherBRNS
- William EnrightBRNS
- Karen A DawesBRNS
- Douglas J SwirskyBRNS
- Gemma BrownBRNS
- Graham GriffithsBRNS
- Geoffrey LynnBRNS
Questions about Robin Wright
- What is Robin Wright's role at Barinthus Biotherapeutics plc.?
- Robin Wright reports to the SEC as director at Barinthus Biotherapeutics plc. (BRNS), according to the latest filing on September 9, 2026.
- Has Robin Wright bought or sold stock recently?
- The most recent open-market purchase was on May 25, 2023: bought 13,750 shares of Vaccitech plc (BRNS) for $36.6K at an average of $2.66.
- How do I get alerts when Robin Wright files?
- Follow Robin Wright on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robin Wright filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robin Wright (SEC CIK 0001851640). Totals count each trade once, skipping amendments whose original is on file, from Feb 10, 2023 on. View on SEC EDGAR